Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Aurora Cannabis ( (TSE:ACB) ) just unveiled an announcement.
Aurora Cannabis announced it will host a conference call on February 5, 2025, to discuss its third-quarter 2025 financial results, which will be released earlier that day. This announcement is part of Aurora’s transparent communication strategy with investors, potentially impacting stakeholder confidence and market perceptions.
More about Aurora Cannabis
Aurora Cannabis Inc. is a leading global medical cannabis company headquartered in Edmonton, Alberta. It operates in both the medical and consumer cannabis markets across Canada, Europe, Australia, and South America. The company’s adult-use brands include Drift, San Rafael ’71, Daily Special, Tasty’s, Being, and Greybeard, while its medical cannabis brands include MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co. Aurora also has a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America. The company prioritizes science, innovation, and high-quality cannabis products to maintain its leadership in the medical, wellness, and adult recreational markets.
YTD Price Performance: -13.33%
Average Trading Volume: 945,855
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $213.2M
Learn more about ACB stock on TipRanks’ Stock Analysis page.
